Page last updated: 2024-10-26

diphenyleneiodonium and Cardiomyopathies, Primary

diphenyleneiodonium has been researched along with Cardiomyopathies, Primary in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, R1
Yin, D1
Sadekova, N1
Deschepper, CF1
de Champlain, J1
Girouard, H1

Other Studies

1 other study available for diphenyleneiodonium and Cardiomyopathies, Primary

ArticleYear
Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters.
    Oxidative medicine and cellular longevity, 2012, Volume: 2012

    Topics: Animals; Aorta; Aspirin; Blood Pressure; Body Weight; Cardiomegaly; Cardiomyopathies; Cardiotonic Ag

2012